Tuberculosis Infection Clinical Trial
Official title:
Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture
Detection of M. tuberculosis in clinical specimens of children has a low sensitivity because specimens are either difficult to collect or contain low levels of M. tuberculosis. Diagnostic criteria are non-specific and culture confirmation is challenging, as sputum samples are not often obtainable from small children and specimens typically have low yield. Although children are typically thought to have paucibacillary disease, they are at greater risk for dissemination of TB. This may allow for detection of Mycobacterium tuberculosis from other bodily fluids than sputum or gastric aspirate, including blood and urine. Unfortunately, little is known about the overall yield from these various specimens. From pilot data collected among adults and children in Tugela Ferry, we know that it is feasible to collect and test various bodily fluid specimens for TB culture. This study aim to test the hypothesis that blood and urine cultures will detect Mycobacterium tuberculosis from children suspected of disseminated TB, and that a proportion of these non-sputum bodily fluids will detect both drug-susceptible and drug-resistant tuberculosis when sputum or gastric culture does not.
Tuberculosis (TB) is a major cause of morbidity and mortality among children in developing
nations. Symptom-based diagnostic criteria are non-specific and culture confirmation is
challenging, as sputum samples are often believed to be to too cumbersome to obtain from
small children and specimens typically have low yield due to the paucibacillary nature of
pediatric TB. Culture confirmation may be obtained in as few as 10% of cases of suspected
pediatric TB. For these reasons, the true extent of the (drug-resistant) TB epidemic in
children is unknown. Thus, either clinicians begin empiric treatment without diagnosis or no
treatment is given at all. Current laboratory methods, if available at all in resource poor
settings, employ smears from expectorated sputa or gastric aspirates which have low
sensitivity in children. While more rapid diagnostic techniques such as PCR based tests have
been developed, there is still poor sensitivity in children. Improving the diagnosis of
pediatric TB must focus on better efforts, including more aggressive strategies to uncover
disseminated disease.
Culture confirmation of disseminated disease can be obtained from blood, urine,
cerebrospinal fluid (CSF), peritoneal and pleural fluid, or purulent material from lymph
node aspirates, abscesses or otorrhea. Unfortunately, little is known about the overall
yield from these various specimens in children. From pilot data collected among children at
NHP, we know that it is feasible to collect and test various bodily fluid specimens for TB
culture.
Although WHO guidelines encourage body fluid collection in order to make a diagnosis of TB
in children, at present in NHP, blood and urine cultures are not obtained for mycobacterial
culture. However, this study seeks to demonstrate that routine investigation of blood and
urine will augment the yield of traditional sputum culture for children in whom disseminated
disease is more likely. Improved culture confirmation will allow DST and a more accurate
description of the drug-resistant TB epidemic for children in the region.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04271397 -
Immunological Biomarkers in Tuberculosis Management
|
N/A | |
Completed |
NCT04545164 -
Computer Aided Screening for Tuberculosis in Low Resource Environments
|
N/A | |
Recruiting |
NCT05766267 -
Short-course Regimens for the Treatment of Pulmonary Tuberculosis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05756582 -
Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
|
||
Enrolling by invitation |
NCT04988984 -
Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)
|
||
Recruiting |
NCT04148053 -
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
|
||
Recruiting |
NCT01689831 -
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
|
Phase 2 | |
Completed |
NCT05945498 -
Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Aged 18-50 Years
|
Phase 1 | |
Not yet recruiting |
NCT06352970 -
Effects of Tuberculosis Infection on Development and Function of the Placenta
|
||
Recruiting |
NCT04575519 -
Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis
|
Phase 2 | |
Recruiting |
NCT05413551 -
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
|
Phase 1 | |
Recruiting |
NCT03941210 -
Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients
|
||
Completed |
NCT04494516 -
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial
|
||
Withdrawn |
NCT03265977 -
A Phase II Study of H56:IC31 in Healthy Adolescents
|
Phase 2 | |
Recruiting |
NCT05069688 -
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
|
Phase 1 | |
Suspended |
NCT05330884 -
BCG Revaccination in Children and Adolescents
|
Phase 3 | |
Recruiting |
NCT05342064 -
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
|
N/A | |
Recruiting |
NCT05236452 -
Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection
|
N/A | |
Recruiting |
NCT05443178 -
Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
|
Phase 1 | |
Recruiting |
NCT05122026 -
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
|
Phase 1/Phase 2 |